Australia markets closed

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.6900-0.0300 (-0.81%)
At close: 04:00PM EDT
3.6900 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 160.22M
Enterprise value 198.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.39
Price/book (mrq)2.19
Enterprise value/revenue 1.77
Enterprise value/EBITDA 24.74

Trading information

Stock price history

Beta (5Y monthly) 1.45
52-week change 3-35.15%
S&P500 52-week change 322.64%
52-week high 36.2900
52-week low 33.6000
50-day moving average 34.2758
200-day moving average 34.4805

Share statistics

Avg vol (3-month) 387.99k
Avg vol (10-day) 395.38k
Shares outstanding 543.42M
Implied shares outstanding 643.77M
Float 835.1M
% held by insiders 17.28%
% held by institutions 178.40%
Shares short (15 Apr 2024) 4672.95k
Short ratio (15 Apr 2024) 45.76
Short % of float (15 Apr 2024) 41.67%
Short % of shares outstanding (15 Apr 2024) 41.55%
Shares short (prior month 15 Mar 2024) 4716.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21319:1000
Last split date 304 Nov 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -3.04%
Operating margin (ttm)3.14%

Management effectiveness

Return on assets (ttm)1.10%
Return on equity (ttm)-4.70%

Income statement

Revenue (ttm)112.25M
Revenue per share (ttm)2.65
Quarterly revenue growth (yoy)-1.00%
Gross profit (ttm)N/A
EBITDA 9.49M
Net income avi to common (ttm)-3.42M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.28M
Total cash per share (mrq)0.1
Total debt (mrq)42.77M
Total debt/equity (mrq)58.53%
Current ratio (mrq)1.85
Book value per share (mrq)1.68

Cash flow statement

Operating cash flow (ttm)14.03M
Levered free cash flow (ttm)13.11M